These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 6672284

  • 41. [The combined (polychemical and radiation) and drug treatment of lymphogranulomatosis patients with generalized lung involvement (stage IV)].
    Baĭsogolov GD, Shakhtarina SV, Afanasova NV.
    Med Radiol (Mosk); 1991; 36(8):4-7. PubMed ID: 1890940
    [Abstract] [Full Text] [Related]

  • 42. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S, Geara F, Nabbout B, Farah RA, Shabb NS, Hajjar T, Khogali M.
    Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Reducing the toxicity of the combined modality therapy of favourable stage Hodgkin's disease.
    Rosenberg SA.
    Eur J Cancer; 1992; 28A(8-9):1379-80. PubMed ID: 1515253
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Therapy of Hodgkin lymphoma: chances of remission are good, treatment tolerance needs improvement].
    Bischoff M.
    MMW Fortschr Med; 2011 Oct 13; 153(41):17. PubMed ID: 22046834
    [No Abstract] [Full Text] [Related]

  • 50. [The treatment of patients with refractory forms of Hodgkin's lymphomas].
    Hubareva HO, Kriachok IA, Tytorenko IB, Aleksyk OM, Novosad OI, Kadnikova TV, Martynchyk AV, Pastushenko IaV, Filonenko KS, Kushchevyĭ IeV.
    Lik Sprava; 2010 Oct 13; (1-2):115-8. PubMed ID: 20608037
    [Abstract] [Full Text] [Related]

  • 51. Reducing treatment-related morbidity and mortality in early-stage Hodgkin's disease and why the recent Southwest Oncology Group Trial is not the way to go.
    Prosnitz LR.
    J Clin Oncol; 2002 May 01; 20(9):2225-8. PubMed ID: 11980993
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Early, intermediate and advanced Hodgkin's lymphoma: modern treatment strategies.
    Diehl V, Fuchs M.
    Ann Oncol; 2007 Jul 01; 18 Suppl 9():ix71-9. PubMed ID: 17631599
    [No Abstract] [Full Text] [Related]

  • 54. Hodgkin's disease in adults. Part I.
    Urba WJ, Longo DL.
    Invest Radiol; 1993 Aug 01; 28(8):737-52. PubMed ID: 8376007
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Classical staging of Hodgkin's disease is inappropriate for selecting patients for clinical trials of intensive therapy: the case for the objective use of prognostic factor information in addition to classical staging.
    Proctor SJ, Taylor PR.
    Leukemia; 1993 Nov 01; 7(11):1911-4; discussion 1917, 1919-20. PubMed ID: 8231262
    [No Abstract] [Full Text] [Related]

  • 57. The contemporary management of Hodgkin disease.
    Hoppe RT.
    Radiology; 1988 Nov 01; 169(2):297-304. PubMed ID: 3140289
    [No Abstract] [Full Text] [Related]

  • 58. Hodgkin's disease: the right dose.
    Prosnitz LR.
    Int J Radiat Oncol Biol Phys; 1990 Sep 01; 19(3):803-4. PubMed ID: 2211229
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Consolidation radiotherapy in the treatment of advanced Hodgkin's disease: is it dead?
    Prosnitz LR.
    Int J Radiat Oncol Biol Phys; 2003 Jul 01; 56(3):605-8. PubMed ID: 12788163
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.